Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.
- 1 August 1994
- journal article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 53 (8), 521-524
- https://doi.org/10.1136/ard.53.8.521
Abstract
To test the hypothesis of a diurnal variation in circulating levels of interleukin-6 (IL-6) and/or tumour necrosis factor-alpha (TNF-alpha) in rheumatoid arthritis and other inflammatory connective tissue diseases. Serum levels of IL-6 and TNF-alpha were measured at three hour intervals from 7:30 to 22:30 in 48 patients with different rheumatic diseases as well as ten healthy controls. In four of the patients with rheumatoid arthritis, serum IL-6 levels were measured before and after one week of treatment with prednisolone 15-20 mg daily. IL-6 and TNF-alpha could not be detected in serum from healthy controls. However, serum IL-6 levels were substantially increased in patients with rheumatoid arthritis. Furthermore, patients with rheumatoid arthritis showed a statistically significant circadian variation in levels of IL-6. Peak values appeared in the morning and low values in the afternoon and evening. In contrast, levels were low and stable in other connective tissue diseases. Levels of TNF-alpha were low in patients with rheumatoid arthritis and high in patients with other connective tissue diseases, but without circadian rhythm. After treatment with prednisolone, levels of serum IL-6 decreased significantly, but the circadian rhythm remained. The circadian rhythm of circulating IL-6 might correspond to the circadian rhythm of symptoms in rheumatoid arthritis. The diurnal variation of IL-6, and possibly other cytokines, might explain the conflicting results previously reported on the inter-relationship between circulating IL-6 levels and disease activity in rheumatoid arthritis.Keywords
This publication has 21 references indexed in Scilit:
- CYTOKINE INTER-RELATIONSHIPS AND THEIR ASSOCIATION WITH DISEASE ACTIVITY IN ARTHRITISRheumatology, 1992
- Production and modulation of interleukin 6 synthesis by synoviocytes derived from patients with arthritic disease.Annals Of The Rheumatic Diseases, 1992
- Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.JCI Insight, 1990
- Thrombopoietic activity of human interleukin‐6FEBS Letters, 1990
- Interleukin-6 in synovial fluid from patients with arthritisClinical Immunology and Immunopathology, 1989
- Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.JCI Insight, 1989
- Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritisEuropean Journal of Immunology, 1988
- Effect of Neuropeptides on Production of Inflammatory Cytokines by Human MonocytesScience, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- lnterleukin-6 (IL-6) in Synovial Fluid and Serum of Patients with Rheumatic DiseasesScandinavian Journal of Rheumatology, 1988